Annual EBIT
-$57.47 M
-$40.89 M-246.68%
31 March 2024
Summary:
LakeShore Biopharma annual earnings before interest & taxes is currently -$57.47 million, with the most recent change of -$40.89 million (-246.68%) on 31 March 2024. During the last 3 years, it has fallen by -$36.11 million (-169.10%). LSB annual EBIT is now -275.34% below its all-time high of -$10.46 million.LSB EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$13.59 M
-$4.73 M-53.33%
30 September 2023
Summary:
LakeShore Biopharma quarterly earnings before interest & taxes is currently -$13.59 million, with the most recent change of -$4.73 million (-53.33%) on 30 September 2023. LSB quarterly EBIT is now -672.32% below its all-time high of $2.37 million, reached on 01 September 2022.LSB Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$22.45 M
-$15.96 M-246.05%
30 September 2023
Summary:
LakeShore Biopharma TTM earnings before interest & taxes is currently -$22.45 million, with the most recent change of -$15.96 million (-246.05%) on 30 September 2023. LSB TTM EBIT is now -3731.03% below its all-time high of $618.20 thousand, reached on 01 September 2022.LSB TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -246.7% | - | - |
| 3 y3 years | -169.1% | - | - |
| 5 y5 years | - | - | - |
LSB EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -275.3% | at low | -672.3% | at low | -3731.0% | at low |
| 5 y | 5 years | -275.3% | at low | -672.3% | at low | -3731.0% | at low |
| alltime | all time | -275.3% | at low | -672.3% | at low | -3731.0% | at low |
LakeShore Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$57.47 M(+246.7%) | - | - |
| Sept 2023 | - | -$13.59 M(+53.3%) | -$22.45 M(+246.0%) |
| June 2023 | - | -$8.86 M(-473.3%) | -$6.49 M(-1149.3%) |
| Mar 2023 | -$16.58 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $2.37 M(-235.2%) | $618.20 K(-135.2%) |
| June 2022 | - | -$1.76 M | -$1.76 M |
| Mar 2022 | -$15.31 M(-28.3%) | - | - |
| Mar 2021 | -$21.35 M | - | - |
FAQ
- What is LakeShore Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for LakeShore Biopharma?
- What is LakeShore Biopharma annual EBIT year-on-year change?
- What is LakeShore Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for LakeShore Biopharma?
- What is LakeShore Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for LakeShore Biopharma?
What is LakeShore Biopharma annual earnings before interest & taxes?
The current annual EBIT of LSB is -$57.47 M
What is the all time high annual EBIT for LakeShore Biopharma?
LakeShore Biopharma all-time high annual earnings before interest & taxes is -$10.46 M
What is LakeShore Biopharma annual EBIT year-on-year change?
Over the past year, LSB annual earnings before interest & taxes has changed by -$40.89 M (-246.68%)
What is LakeShore Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of LSB is -$13.59 M
What is the all time high quarterly EBIT for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly earnings before interest & taxes is $2.37 M
What is LakeShore Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of LSB is -$22.45 M
What is the all time high TTM EBIT for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM earnings before interest & taxes is $618.20 K